|Articles|October 29, 2003

CAD wins nod for Fischer FFDM

The FDA has approved the use of CADX Systems' Second Look Digital computer-aided detection system as an integral part of Fischer Imaging's SenoScan TrueView full-field digital mammography system. The agency had approved the two systems previously for

The FDA has approved the use of CADX Systems' Second Look Digital computer-aided detection system as an integral part of Fischer Imaging's SenoScan TrueView full-field digital mammography system. The agency had approved the two systems previously for sale as stand-alone products.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Related Content

FDA Clears Updated AI Mammography Software for Breast Arterial Calcification Detection

FDA Clears Updated AI Mammography Software for Breast Arterial Calcification Detection

August 17th 2026

Diagnostic Imaging’s Weekly Scan: August 9 — August 15

Diagnostic Imaging’s Weekly Scan: August 9 — August 15

August 16th 2026

Breast Imaging in Focus: What New Research Reveals About Contrast-Enhanced Mammography in Prevalence and Incidence Screening Rounds

Breast Imaging in Focus: What New Research Reveals About Contrast-Enhanced Mammography in Prevalence and Incidence Screening Rounds

ByManisha Bahl, MD

August 13th 2026

Diagnostic Imaging's Weekly Scan: August 2, 2026 — August 8, 2026

Diagnostic Imaging's Weekly Scan: August 2 — August 8

ByDiagnostic Imaging Staff

August 9th 2026

Breast Imaging in Focus Series: Recent Episode Highlights

Breast Imaging in Focus Series: Recent Episode Highlights

ByManisha Bahl, MD

August 7th 2026

Latest CME

25th Annual International Congress on the Future of Breast Cancer® East

25th Annual International Congress on the Future of Breast Cancer® East

Joyce O’Shaughnessy, MD

25th Annual International Congress on the Future of Breast Cancer® West

25th Annual International Congress on the Future of Breast Cancer® West

Sara A. Hurvitz, MD, FACP; Joyce O’Shaughnessy, MD

Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care

Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Nerina McDonald, MSPAS, PA-C; Scott T. Tagawa, MD, MS, FACP, FASCO

Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified

Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO

Radioligand Therapy 101: The Science Behind the Strategy

Radioligand Therapy 101: The Science Behind the Strategy

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO

Satellite Symposia at the Annual Radiation Oncology Meeting

In-Person + Virtual Event

Satellite Symposia at the Annual Radiation Oncology Meeting

September 27-28, 2026

26th Annual International Lung Cancer Congress

26th Annual International Lung Cancer Congress

Roy S. Herbst, MD, PhD; Sandip Patel, MD, FASCO; Heather A. Wakelee, MD, FASCO

Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies

Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies

Ana Kiess, MD, PhD; Erin Grady, MD, CCD, FACNM, FSNMMI; Himanshu Nagar, MD, MS; Scott T. Tagawa, MD, MS, FASCO, FACP

Trending on Diagnostic Imaging

Interventional Radiology in Focus: Emphasizing the Appeal, Advances and Awareness for Interventional Radiology

Could Photon Counting CT Enhance Local Staging of Bladder Cancer?

FDA Clears Updated AI Mammography Software for Breast Arterial Calcification Detection

FDA Clears NeuroQuant PET for Assessment of Neurological Conditions

Emerging CAIX PET Agent Garners FDA Breakthrough Therapy and Fast Track Designations for ccRCC